Humacyte, Inc. (HUMA)
(Delayed Data from NSDQ)
$6.42 USD
+0.94 (17.15%)
Updated May 14, 2024 04:00 PM ET
After-Market: $6.42 0.00 (0.00%) 5:14 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
Humacyte, Inc. [HUMA]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: Humacyte, Inc.
Industry: Unclassified
We HAVe a BLA Now; FDA Application Submitted; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Humacyte, Inc.
Industry: Unclassified
We Could HAVe a New Alternative for Treating Vascular Injury Soon; Initiating at Buy With a $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Humacyte, Inc.
Industry: Unclassified
|